Please login to the form below

Value of Medicines

By focusing on cost are we obscuring the true value of medicines?

FrameIn an age of financial constraint and austerity questions of value are inevitably asked of pharma.

David Coleiro, Paula Lashley and John Grime take a look at how society values medicines, the role of health technology assessment (HTA) bodies like NICE, what value means when it comes to end-of-life care and ask whether the need for cost containment has blurred the perception of value. 

David Coleiro is a Partner and Paula Lashley and John Grime are Consultants at Strategic North, a healthcare marketing strategy consultancy that works with clients to build inspiring, joined-up strategic stories. 

• This article first appeared in the September 2012 issue of PME (Pharmaceutical Market Europe) and can be viewed online or downloaded as a pdf to read later


PDF File: 1.6 MB

14th March 2013


PDF File: 1.6 MB



Company Details

Strategic North

+44(0)161 942 9610

Contact Website

Media House
Richmond Road
WA14 2TT
United Kingdom

Latest content on this profile

Strategic Tales
Strategic Tales: Global stories shaping the world of tomorrow
Strategic North
Partnership in practice? Joint industry and pharma working

Strategic North
What's holding you back?
The pharmaceutical industry is broken!” How many times now have we heard this kind of doom-mongering?
Strategic North
Strategic North Little Book of Blogs
Welcome to our Little Book of Blogs. We are a curious bunch at Strategic North, and constantly endeavour to bring external stimulus to our thinking, drive debate in our industry and have fun along the way. These three elements are integral to the blogs and articles we write.
Strategic North
Congratulations, well done John!
Following a strong period of growth in 2013, healthcare marketing agency Strategic North, is delighted to announce the promotion of John Grime to Director from January 2014.
Strategic North
Untapping the unconscious: the next revolution in pharma marketing
In this article published in September 2013 in Pharmafile, we talk about the future of marketing, behavioural economics and the unconscious mind.
Strategic North